Abstract
Tissue methylmalonic acid (MMA) accumulation is the biochemical hallmark of methylmalonic acidemia. Clinically, the disease is characterized by progressive neurological deterioration and renal failure, whose pathophysiology is still undefined. In the present study we investigated the effect of acute MMA administration on some important parameters of brain neurotransmission in cerebral cortex of rats, namely Na+, K+-ATPase, ouabain-insensitive ATPases and acetylcholinesterase activities, in the presence or absence of kidney injury induced by gentamicin administration. Initially, thirty-day old Wistar rats received one intraperitoneal injection of saline or gentamicin (70 mg/kg). One hour after, the animals received three consecutive subcutaneous injections of MMA (1.67 μmol/g) or saline, with an 11 h interval between each injection. One hour after the last injection the animals were killed and the cerebral cortex isolated. MMA administration by itself was not able to modify Na+, K+-ATPase, ATPases ouabain-insensitive or acetylcholinesterase activities in cerebral cortex of young rats. In rats receiving gentamicin simultaneously with MMA, it was observed an increase in the activity of acetylcholinesterase activity in cerebral cortex, without any alteration in the activity of the other studied enzymes. Therefore, it may be speculated that cholinergic imbalance may play a role in the pathogenesis of the brain damage. Furthermore, the pathophysiology of tissue damage cannot be exclusively attributed to MMA toxicity, and control of kidney function should be considered as a priority in the management of these patients, specifically during episodes of metabolic decompensation when MMA levels are higher.
Similar content being viewed by others
References
Bartus RT (2000) On neurodegenerative diseases, models, and treatment strategies: lessons learned and lessons forgotten a generation following the cholinergic hypothesis. Exp Neurol 163:495–529
Beeri R, Andres C, Lev-Lehman E, Timberg R, Huberman T, Shani M, Soreq H (1995) Transgenic expression of human acetylcholinesterase induces progressive cognitive deterioration in mice. Curr Biol 5:1063–1071
Brusque AM, Borba Rosa R, Schuck PF, Dalcin KB, Ribeiro CA, Silva CG, Wannmacher CM, Dutra-Filho CS, Wyse AT, Briones P, Wajner M (2002) Inhibition of the mitochondrial respiratory chain complex activities in rat cerebral cortex by methylmalonic acid. Neurochem Int 40:593–601
Chan KM, Delfert D, Junger KD (1986) A direct colorimetric assay for Ca2 + -stimulated ATPase activity. Anal Biochem 157:375–380
Chandler RJ, Venditti CP (2005) Genetic and genomic systems to study methylmalonic acidemia. Mol Genet Metab 86:34–43
Clothier JC, Chakrapani A, Preece MA, McKiernan P, Gupta R, Macdonald A, Hulton SA (2011) Renal transplantation in a boy with methylmalonic acidaemia. J Inherit Metab Dis 34:695–700
D’Angio CT, Dillon MJ, Leonard JV (1991) Renal tubular dysfunction in methylmalonic acidemia. Eur J Pediatr 150:259–263
Dionisi-Vici C, Deodato F, Roschinger W, Rhead W, Wilcken B (2006) Classical’ organic acidurias, propionic aciduria, methyl- malonic aciduria and isovaleric aciduria: long-term outcome and effects of expanded newborn screening using tandem mass spectrometry. J Inherit Metab Dis 29:383–389
Dutra JC, Wajner M, Wannmacher CM, Wannmacher LE, Pires RF, Rosa-júnior A (1991) Effect of postnatal methylmalonate administration on adult rat behavior. Braz J Med Bio Res 24:595–605
Easton A, Douchamps V, Eacott M, Lever C (2012) A specific role for septohippocampal acetylcholine in memory? Neuropsychologia 50:3156–3168
Ellman GL, Courtney KD, Andres V Jr, Feather-Stone RM (1961) A new and rapid colorimetric determination of acetylcholinesterase activity. Biochem Pharmacol 7:88–95
Fenton WA, Gravel RA, Rosenblatt DS (2001) Disorders of propionate and methylmalonate metabolism. In: Scriver CR, Beaudet AL, Sly WS, Valle D (eds) The metabolic and molecular bases of inherited disease, 8ath edn. McGraw-Hill, New York, pp 2165–2193
Gao Y, Guan W, Wang J, Zhang Y, Li Y, Han L (2009) Fractional anisotropy for assessment of white matter tracts injury in methylmalonic acidemia. Chin Med J 122:945–949
García-Ayllón MS, Cauli O, Silveyra MX, Rodrigo R, Candela A, Campañ A, Jover R, Pérez-Mateo M, Martínez S, Felipo V, Sáez-Valero J (2008) Brain cholinergic impairment in liver failure. Brain 131:2946–2956
Giacobini E (2003) Cholinesterases: new roles in brain function and in Alzheimer’s disease. Neurochem Res 28:515–522
Herlenius E, Lagercrantz H (2004) Development of neurotransmitter systems during critical periods. Exp Neurol 190:S8–S21
Hoffmann GF, Meier-Augenstein W, Stocker S, Surtees R, Rating D, Nyhan WL (1993) Physiology and pathophysiology of organic acids in cerebrospinal fluids. J Inherit Metab Dis 16:648–666
Jones DH, Matus AI (1974) Isolation of synaptic plasma membrane from brain by combined flotation-sedimentation density gradient centrifugation. Biochim Biophys Acta 356:276–287
Kashtan CE, Abousedira M, Rozen S, Manivel JC, McCann M, Tuchman M (1998) Chronic administration of methylmaloic acid (MMA) to rats causes proteinuria and renal tubular injury. Pediatr Res 43:309
Keseler IM, Collado-Vides J, Gama-Castro S, Ingraham J, Paley S, Paulsen IT, Peralta-Gil M, Karp PD (2005) EcoCyc: a comprehensive database resource for Escherichia coli. Nucleic Acids Res 33:334–337
Khishna S, Andersson AM, Semsey S, Sneppen K (2006) Structure and function of negative feedback loops at the interface of genetic and metabolic networks. Nucleic Acids Res 34:2455–2462
Kölker S, Okun JG (2005) Methylmalonic acid-an endogenous toxin? Cell Mol Life Sci 62:621–624
Kölker S, Schwab M, Hörster F, Sauer S, Hinz A, Wolf NI, Mayatepek E, Hoffmann GF, Smeitink JA, Okun JG (2003) Methylmalonic acid, a biochemical hallmark of methylmalonic acidurias but no inhibitor of mitochondrial respiratory chain. J Biol Chem 278:47388–47393
Lin TH, Sawada Y, Sugiyama Y, Iga T, Hanano M (1987) Inhibition of blood–brain barrier permeability to DL-propranolol by serum from acute renal failure rats. Biochem Pharmacol 36:3425–3431
Liu M, Liang Y, Chigurupati S, Lathia JD, Pletnikov M, Sun Z, Crow M, Ross CA, Mattson MP, Rabb H (2008) Acute kidney injury leads to inflammation and functional changes in the brain. J Am Soc Nephrol 19:1360–1370
Lotti M (1995) Cholinesterase inhibition: complexities in interpretation. Clin Chem 41:1814–1818
Lowry OH, Rosebrough NJ, Farr AL, Randall RJ (1951) Protein measurement with the folin phenol reagent. J Biol Chem 193:265–275
Lubrano R, Elli M, Rossi M, Travasso E, Raggi C, Barsotti P, Carducci C, Berloco P (2007) Renal transplant in methylmalonic acidemia: could it be the best option? Report on a case at 10 years and review of the literature. Pediatr Nephrol 22:1209–1214
Machado DG, Cunha MP, Neis VB, Balen GO, Colla A, Grando J, Brocardo PS, Bettio LE, Capra JC, Rodrigues AL (2012a) Fluoxetine reverses depressive-like behaviors and increases hippocampal acetylcholinesterase activity induced by olfactory bulbectomy. Pharmacol Biochem Behav 103:220–229
Machado DG, Cunha MP, Neis VB, Balen GO, Colla AR, Grando J, Brocardo PS, Bettio LE, Dalmarco JB, Rial D, Prediger RD, Pizzolatti MG, Rodrigues AL (2012b) Rosmarinus officinalis L. hydroalcoholic extract, similar to fluoxetine, reverses depressive-like behavior without altering learning deficit in olfactory bulbectomized mice. J Ethnopharmacol 143:158–169
Maciel EN, Kowaltowski AJ, Schwalm FD, Rodrigues JM, Souza DO, Vercesi AE, Wajner M, Castilho RF (2004) Mitochondrial permeability transition in neuronal damage promoted by Ca2+ and respiratory chain complex II inhibition. J Neurochem 90:1025–1035
Malfatti CR, Royes LF, Francescato L, Sanabria ER, Rubin MA, Cavalheiro EA, Mello CF (2003) Intrastriatal methylmalonic acid administration induces convulsions and TBARS production, and alters Na +, K + -ATPase activity in the rat striatum and cerebral cortex. Epilepsia 44:761–767
Manoli I, Venditti CP (2005) Methylmalonic Acidemia. Gene Reviews Bookshelf ID: NBK1231PMID: 20301409.
Melo JB, Agostinho P, Oliveira CR (2003) Involvement of oxidative stress in the enhancement of acetylcholinesterase activity induced by amyloid beta-peptide. Neurosci Res 45:117–127
Melo DR, Kowaltowski AJ, Wajner M, Castilho RF (2011) Mitochondrial energy metabolism in neurodegeneration associated with methylmalonic acidemia. J Bioenerg Biomembr 43:39–46
Michel SJ, Given CA 2nd, Robertson WC Jr (2004) Imaging of the brain, including diffusion-weighted imaging in methylmalonic acidemia. Pediatr Radiol 34:580–582
Mirandola SR, Melo DR, Schuck PF, Ferreira GC, Wajner M, Castilho RF (2008) Methylmalonate inhibits succinate-supported oxygen consumption by interfering with mitochondrial succinate uptake. J Inherit Metab Dis 31:44–54
Morath MA, Okun JG, Müller IB, Sauer SW, Hörster F, Hoffmann GF, Kölker S (2008) Neurodegeneration and chronic renal failure in methylmalonic aciduria - A pathophysiological approach. J Inherit Metab Dis 31:35–43
Morath MA, Hörster F, Sauer SW (2012) Renal dysfunction in methylmalonic acidurias: review for the pediatric nephrologist. Pediatr Nephrol In press
Naud J, Laurin LP, Michaud J, Beauchemin S, Leblond FA, Pichette V (2012) Effects of chronic renal failure on brain drug transporters in rats. Drug Metab Dispos 40:39–46
Nicolaides P, Leonard J, Surtees R (1998) Neurological outcome of methylmalonic acidemia. Arch Dis Child 78:508–512
Okun JG, Hörster F, Farkas LM, Feyh P, Hinz A, Sauer S, Hoffmann GF, Unsicker K, Mayatepek E, Kölker S (2002) Neurodegeneration in methylmalonic aciduria involves inhibition of complex II and the tricarboxylic acid cycle, and synergistically acting excitotoxicity. J Biol Chem 277:14674–14680
Petronilho F, Constantino L, Souza B, Reinke A, Martins MR, Fraga CM, Ritter C, Dal-pizzol F (2009) Efficacy of the combination of N-acetylcysteine and desferrioxamine in the prevention and treatment of gentamicin-induced acute renal failure in male Wistar rats. Nephrol Dial Transplant 24:2077–2082
Petrov KA, Malomouzh AI, Kovyazina IV, Krejci E, Nikitashina AD, Svetlana E, Proskurina SE, Zobov VV, Nikolsky EE (2013) Regulation of acetylcholinesterase activity by nitric oxide in rat neuromuscular junction via N-methyl-D-aspartate receptor activation. Eur J Neurosci 37:181–189
Pettenuzzo LF, Schuck PF, Wyse AT, Wannamacher CM, Dutra-Filho CS, Netto CA, Wajner M (2003a) Ascorbic acid prevents water maze behavioral deficits caused by early postnatal methylmalonic acid administration in the rat. Brain Res 976:234–242
Pettenuzzo LF, Wyse AT, Wannmacher CM, Dutra-Filho CS, Netto CA, Wajner M (2003b) Evaluation of the effect of chronic administration of drugs on rat behavior in the water maze task. Brain Res Brain Res Protoc 12:109–115
Pettenuzzo LF, Ferreira GC, Schmidt AL, Dutra-Filho CS, Wyse AT, Wajner M (2006) Differential inhibitory effects of methylmalonic acid on respiratory chain complex activities in rat tissues. Inter J Devel Neurosc 24:45–52
Prust MJ, Gropman AL, Hauser N (2011) New frontiers in neuroimaging applications to inborn errors of metabolism. Mol Genet Metab 104:195–205
Ratnakumari L, Qureshi IA, Maysinger D, Butterworth RF (1995) Developmental deficiency of the cholinergic system in congenitally hyperammonemicspf mice: effect of acetyl-L-carnitine. J Pharmacol Exp Ther 274:437–443
Ribas GS, Scherer EB, Ferreira AG, Schmitz F, Wyse AT, Rodrigues D, Nascimento S, Garcia SC, Wajner M, Vargas CR (2012) Reduction of butyrylcholinesterase activity in plasma from patients with disorders of propionate metabolism is prevented by treatment with L-carnitine and protein restriction. Clin Biochem 45:77–81
Salgado H, Santos-Zavaleta A, Gama-Castro S, Millan-Zarate D, Diaz-Peredo E, Sanchez-Solano F, Perez-Rueda E, Bonavides-Martinez C, Collado-Vides J (2001) Regulon DB (version 3.2): transcriptional regulation and operon organization in Escherichia coli K-12. Nucl Acids Res 29:72–74
Savini L, Gaeta A, Fattorusso C, Catalanotti B, Campiani G, Chiasserini L, Pellerano C, Novellino E, McKissic D, Saxena A (2003) Specific targeting of acetylcholinesterase and butyrylcholinesterase recognition sites. Rational design of novel, selective, and highly potent cholinesterase inhibitors. J Med Chem 46:1–4
Schuck PF, Rosa RB, Pettenuzzo LF, Sitta A, Wannmacher CM, Wyse AT, Wajner M (2004) Inhibition of mitochondrial creatine kinase activity from rat cerebral cortex by methylmalonic acid. Neurochem Int 45:661–667
Schuck PF, Alves L, Pettenuzzo LF, Felisberto F, Rodrigues LB, Freitas BW, Petronilho F, Dal-Pizzol F, Streck EL, Ferreira GC (2013a) Acute renal failure potentiates methylmalonate-induced oxidative stress in brain and kidney of rats. Free Rad Res 47:233–240
Schuck PF, Januário SB, Simon KR, Scaini G, Mafioleti RL, Malgarin F, Pettenuzzo LF, Streck EL, Ferreira GC (2013b) Acute renal failure potentiates brain energy dysfunction elicited by methylmalonic acid. Int J Dev Neurosci in press
Schulpis KH, Kalimeris K, Bakogiannis C, Tsakiris T, Tsakiris S (2006) The effect of in vitro homocystinuria on the suckling rat hippocampal acetylcholinesterase. Metab Brain Dis 21:21–28
Soreq H, Seidman S (2001) Acetylcholinesterase new roles for and old actor. Nat Rev Neurosci 2:294–302
Srinivas KV, Want MA, Freigoun OS, Balkrishna N (2001) Methylmalonic acidemia with renal involvement: a case report and review of literature. Saudi J Kidney Dis Trasnplant 12:49–53
Strada O, Vyas S, Hirsch EC, Ruberg M, Brice A, Agid Y, Javoy-Agid F (1992) Decreased choline acetyltransferase mRNA expression in the nucleus basalis of Meynert in Alzheimer disease: an in situ hybridization study. Proc Natl Acad Sci USA 89:9549–9553
Sussman JL, Harel M, Frolow F, Oefner C, Goldman A, Toker L, Silman I (1991) Atomic structure of acetylcholinesterase from Torpedo californica: a prototypic acetylcholine-binding protein. Science 253:872–879
Toyoshima S, Watanabe F, Saido H, Miyatake K, Nakano Y (1995) Excretion from rats of ketone bodies and methylmalonic acid in urine resulting from dietary vitamin B12 deficiency. Biosci Biotechnol Biochem 59:1598–1599
Trinh BC, Melhem ER, Barker PB (2001) Multi-slice proton MR spectroscopy and diffusion-weighted imaging in methylmalonic acidemia: report of two cases and review of the literature. AJNR Am J Neuroradiol 22:831–833
Tsakiris S, Deliconstantinos G (1984) Influence of phosphatidylserine on (Na++K+)-stimulated ATPase and acetylcholinesterase activities of dog brain synaptosomal plasma membranes. Biochem J 220:301–307
Van Calcar SC, Harding CO, Lyne P, Hogan K, Banerjee R, Sollinger H, Rieselbach RE, Wolff JA (1998) Renal transplantation in a patient with methylmalonic acidemia. J Inherit Metab Dis 21:729–737
Wajner M, Barschak AG, Luft AP, Pires R, Grillo E, Lohr A, Funayama C, Sanseverino MT, Giugliani R, Vargas CR (2001) Acidúrias orgânicas: diagnóstico em pacientes de alto risco no Brasil. J Pediatr (Rio J) 77:401–406
Wiley RG, Berbos TG, Deckwerth TL, Johnson EM, Lappi DA Jr (1995) Destruction of the cholinergic basal forebrain using immunotoxin to rat NGF receptor: modeling the cholinergic degeneration of Alzheimer’s disease. J Neurol Sci 128:157–166
Wyse AT, Streck EL, Barros SV, Brusque AM, Zugno AI, Wajner M (2000) Methylmalonic administration decreases Na+, K + -ATPase activity in cerebral cortex of rats. Neuro Report 11:2331–2334
Zugno AI, Pereira LO, Mattos C, Scherer EBS, Netto CA, Wyse ATS (2008) Guanadinoacetato administration increases acetylcholinesterase activity in striatum of rats and impairs retention of an inhibitory avoidance task. Metab Brain Dis 23:189–198
Acknowledgments
This work was supported by grants from CNPq, FAPESC and PROPEX/UNESC.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Affonso, A.C., Machado, D.G., Malgarin, F. et al. Increased susceptibility of brain acetylcholinesterase activity to methylmalonate in young rats with renal failure. Metab Brain Dis 28, 493–500 (2013). https://doi.org/10.1007/s11011-013-9396-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11011-013-9396-0